Outcomes of rituximab therapy in refractory lupus: A meta-analysis

OBJECTIVE: Conventional treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) is associated with damage accrual, hence increased morbidity rate. Off-label use of rituximab (RTX) has shown significant promise in this patient group; however, data are still controversial. We aimed to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Rheumatol
Main Authors: Alshaiki, Fatma, Obaid, Elaf, Almuallim, Abdulqader, Taha, Rabab, El-haddad, Hadeel, Almoallim, Hani
Formato: Artigo
Idioma:Inglês
Publicado em: Medical Research and Education Association 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6072690/
https://ncbi.nlm.nih.gov/pubmed/30185361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2018.17096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados